IDEAS home Printed from https://ideas.repec.org/r/wly/hlthec/v23y2014i6p729-742.html

An Australian Discrete Choice Experiment To Value Eq‐5d Health States

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Michał Jakubczyk, 2023. "What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(7), pages 1217-1233, September.
  2. R. Hoorn & A. Donders & M. Oppe & P. Stalmeier, 2014. "The Better than Dead Method: Feasibility and Interpretation of a Valuation Study," PharmacoEconomics, Springer, vol. 32(8), pages 789-799, August.
  3. Suzi Claflin & Julie A. Campbell & Richard Norman & Deborah F. Mason & Tomas Kalincik & Steve Simpson-Yap & Helmut Butzkueven & William M. Carroll & Andrew J. Palmer & C. Leigh Blizzard & Ingrid van d, 2023. "Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(6), pages 939-950, August.
  4. Brendan Mulhern & Richard Norman & Koonal Shah & Nick Bansback & Louise Longworth & Rosalie Viney, 2018. "How Should Discrete Choice Experiments with Duration Choice Sets Be Presented for the Valuation of Health States?," Medical Decision Making, , vol. 38(3), pages 306-318, April.
  5. Arne Risa Hole & Richard Norman & Rosalie Viney, 2016. "Response Patterns in Health State Valuation Using Endogenous Attribute Attendance and Latent Class Analysis," Health Economics, John Wiley & Sons, Ltd., vol. 25(2), pages 212-224, February.
  6. Sullivan, Trudy & McCarty, Georgia & Ombler, Franz & Turner, Robin & Mulhern, Brendan & Hansen, Paul, 2024. "Creating an SF-6Dv2 social value set for New Zealand," Social Science & Medicine, Elsevier, vol. 354(C).
  7. Spencer, Anne & Rivero-Arias, Oliver & Wong, Ruth & Tsuchiya, Aki & Bleichrodt, Han & Edwards, Rhiannon Tudor & Norman, Richard & Lloyd, Andrew & Clarke, Philip, 2022. "The QALY at 50: One story many voices," Social Science & Medicine, Elsevier, vol. 296(C).
  8. Edel Doherty & Anna Hobbins & David G. T. Whitehurst & Ciaran O’Neill, 2021. "An Exploration on Attribute Non-attendance Using Discrete Choice Experiment Data from the Irish EQ-5D-5L National Valuation Study," PharmacoEconomics - Open, Springer, vol. 5(2), pages 237-244, June.
  9. Jing Wu & Shitong Xie & Xiaoning He & Gang Chen & Gengliang Bai & Da Feng & Ming Hu & Jie Jiang & Xiaohui Wang & Hongyan Wu & Qunhong Wu & John E. Brazier, 2021. "Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension," PharmacoEconomics, Springer, vol. 39(5), pages 521-535, May.
  10. Brendan Mulhern & Nick Bansback & Arne Risa Hole & Aki Tsuchiya, 2017. "Using Discrete Choice Experiments with Duration to Model EQ-5D-5L Health State Preferences," Medical Decision Making, , vol. 37(3), pages 285-297, April.
  11. Anna Selivanova & Erik Buskens & Paul F. M. Krabbe, 2018. "Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values," PharmacoEconomics, Springer, vol. 36(6), pages 715-725, June.
  12. Bansback, Nick & Hole, Arne Risa & Mulhern, Brendan & Tsuchiya, Aki, 2014. "Testing a discrete choice experiment including duration to value health states for large descriptive systems: Addressing design and sampling issues," Social Science & Medicine, Elsevier, vol. 114(C), pages 38-48.
  13. Koji Makino & Dominic Tilden & Carmel Guarnieri & Mia Mudge & Ian J. Baguley, 2019. "Cost Effectiveness of Long-Term Incobotulinumtoxin-A Treatment in the Management of Post-stroke Spasticity of the Upper Limb from the Australian Payer Perspective," PharmacoEconomics - Open, Springer, vol. 3(1), pages 93-102, March.
  14. Dennis A. Revicki & Madeleine T. King & Rosalie Viney & A. Simon Pickard & Rebecca Mercieca-Bebber & James W. Shaw & Fabiola Müller & Richard Norman, 2021. "United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument," Medical Decision Making, , vol. 41(4), pages 485-501, May.
  15. Richard Norman & Paula Cronin & Rosalie Viney, 2012. "Deriving utility weights for the EQ-5D-5L using a discrete choice experiment. CHERE Working Paper 2012/01," Working Papers 2012/01, CHERE, University of Technology, Sydney.
  16. Melita J. Giummarra & Rongbin Xu & Yuming Guo & Joanna F. Dipnall & Jennie Ponsford & Peter A. Cameron & Shanthi Ameratunga & Belinda J. Gabbe, 2021. "Driver, Collision and Meteorological Characteristics of Motor Vehicle Collisions among Road Trauma Survivors," IJERPH, MDPI, vol. 18(21), pages 1-16, October.
  17. Sanjeewa Kularatna & Jennifer A. Whitty & Newell W. Johnson & Ruwan Jayasinghe & Paul A. Scuffham, 2015. "Development of an EORTC-8D Utility Algorithm for Sri Lanka," Medical Decision Making, , vol. 35(3), pages 361-370, April.
  18. Ole Marten & Brendan Mulhern & Nick Bansback & Aki Tsuchiya, 2020. "Implausible States: Prevalence of EQ-5D-5L States in the General Population and Its Effect on Health State Valuation," Medical Decision Making, , vol. 40(6), pages 735-745, August.
  19. Brendan Mulhern & Richard Norman & Paula Lorgelly & Emily Lancsar & Julie Ratcliffe & John Brazier & Rosalie Viney, 2017. "Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?," PharmacoEconomics, Springer, vol. 35(4), pages 439-451, April.
  20. Marcel F. Jonker & Bas Donkers & Esther de Bekker‐Grob & Elly A. Stolk, 2019. "Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experiments," Health Economics, John Wiley & Sons, Ltd., vol. 28(3), pages 350-363, March.
  21. Brendan Mulhern & Richard Norman & Deborah J. Street & Rosalie Viney, 2019. "One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation," PharmacoEconomics, Springer, vol. 37(1), pages 29-43, January.
  22. John Brazier & Roberta Ara & Donna Rowen & Helene Chevrou-Severac, 2017. "A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models," PharmacoEconomics, Springer, vol. 35(1), pages 21-31, December.
  23. Richard Norman & Rosalie Viney & John Brazier & Leonie Burgess & Paula Cronin & Madeleine King & Julie Ratcliffe & Deborah Street, 2014. "Valuing SF-6D Health States Using a Discrete Choice Experiment," Medical Decision Making, , vol. 34(6), pages 773-786, August.
  24. Kaambwa, Billingsley & Lancsar, Emily & McCaffrey, Nicola & Chen, Gang & Gill, Liz & Cameron, Ian D. & Crotty, Maria & Ratcliffe, Julie, 2015. "Investigating consumers' and informal carers' views and preferences for consumer directed care: A discrete choice experiment," Social Science & Medicine, Elsevier, vol. 140(C), pages 81-94.
  25. Nan Luo & Annushiah Vasan Thakumar & Ling Jie Cheng & Zhihao Yang & Kim Rand & Yin Bun Cheung & Julian Thumboo, 2025. "Developing an EQ-5D-5L Value Set for Singapore," PharmacoEconomics, Springer, vol. 43(12), pages 1419-1431, December.
  26. Richard Norman & Rebecca Mercieca‐Bebber & Donna Rowen & John E. Brazier & David Cella & A. Simon Pickard & Deborah J. Street & Rosalie Viney & Dennis Revicki & Madeleine T. King & On behalf of the Eu, 2019. "U.K. utility weights for the EORTC QLU‐C10D," Health Economics, John Wiley & Sons, Ltd., vol. 28(12), pages 1385-1401, December.
  27. Nicolas Krucien & Verity Watson & Mandy Ryan, 2017. "Is Best–Worst Scaling Suitable for Health State Valuation? A Comparison with Discrete Choice Experiments," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 1-16, December.
  28. Madeleine T. King & D. A. Revicki & R. Norman & F. Müller & R.C. Viney & A. S. Pickard & D. Cella & J. W. Shaw, 2024. "United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument," PharmacoEconomics - Open, Springer, vol. 8(1), pages 49-63, January.
  29. Hosein Ameri & Thomas G. Poder, 2025. "Comparison of four approaches in eliciting health state utilities with SF-6Dv2," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 26(4), pages 589-604, June.
  30. Edward J. D. Webb & John O’Dwyer & David Meads & Paul Kind & Penny Wright, 2020. "Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(5), pages 787-800, July.
  31. Sullivan, Trudy & Hansen, Paul & Ombler, Franz & Derrett, Sarah & Devlin, Nancy, 2020. "A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’," Social Science & Medicine, Elsevier, vol. 246(C).
  32. Chau L. B. Ho & Angela Brennan & Diem T. Dinh & Jeffrey Lefkovits & Danny Liew & Si Si & Christopher M. Reid & Richard Norman, 2022. "Prior Coronary Artery Bypass Graft Surgery Impacts 30-day Quality of Life after Percutaneous Coronary Intervention: Evidence from the Victorian Cardiac Outcomes Registry (VCOR)," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 17(6), pages 3415-3426, December.
  33. Shitong Xie & Tianxin Pan & Juan Manuel Ramos-Goni & Brendan Mulhern & Zhihao Yang & Richard Norman & Nancy Devlin & Feng Xie, 2025. "Eliciting and Anchoring Health State Preferences Using Discrete Choice Experiments Among Adults, Adolescents, and Children," PharmacoEconomics, Springer, vol. 43(11), pages 1353-1366, November.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.